Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
BMC Cardiovascular Disorders
|
May 17, 2020
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
Mario Iannaccone, Umberto Barbero, Michele De Benedictis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 22, 2020
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations
Guglielmo Gallone, Fabrizio D'Ascenzo, Federico Conrotto, et al.
Journal of Clinical Medicine
|
May 28, 2022
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic
Roberto Licordari, Alessandro Sticchi, Filippo Mancuso, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
Minerva Cardiology and Angiology
|
October 28, 2022
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality
Alessandro Sticchi, Francesco Costa, Saverio Muscoli, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
Journal of the American College of Cardiology
|
September 4, 2020
Timing of Oral P2Y<sub>12</sub> Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Giuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 21, 2019
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes
Mario Iannaccone, Fabrizio D'Ascenzo, Guglielmo Gallone, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
BMC Cardiovascular Disorders
|
May 17, 2020
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
Mario Iannaccone, Umberto Barbero, Michele De Benedictis, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 22, 2020
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations
Guglielmo Gallone, Fabrizio D'Ascenzo, Federico Conrotto, et al.
Journal of Clinical Medicine
|
May 28, 2022
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic
Roberto Licordari, Alessandro Sticchi, Filippo Mancuso, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
Minerva Cardiology and Angiology
|
October 28, 2022
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality
Alessandro Sticchi, Francesco Costa, Saverio Muscoli, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
Journal of the American College of Cardiology
|
September 4, 2020
Timing of Oral P2Y<sub>12</sub> Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Giuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
December 21, 2019
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes
Mario Iannaccone, Fabrizio D'Ascenzo, Guglielmo Gallone, et al.
Page
of 13